Eledon Pharmaceuticals (ELDN) Short Interest Ratio & Short Volume → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free ELDN Stock Alerts $2.02 +0.16 (+8.60%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Eledon Pharmaceuticals Short Interest DataCurrent Short Volume106,900 sharesPrevious Short Volume36,400 sharesChange Vs. Previous Month+193.68%Dollar Volume Sold Short$220,214.00Short Interest Ratio / Days to Cover1.4Last Record DateMarch 31, 2024Outstanding Shares24,813,000 sharesPercentage of Shares Shorted0.43%Today's Trading Volume313,122 sharesAverage Trading Volume87,274 sharesToday's Volume Vs. Average359% Short Selling Eledon Pharmaceuticals ? Sign up to receive the latest short interest report for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatELDN Short Interest Over TimeELDN Days to Cover Over TimeELDN Percentage of Float Shorted Over Time Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Eledon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024106,900 shares $220,214.00 +193.7%N/A1.4 $2.06 3/15/202436,400 shares $56,056.00 -6.7%N/A0.5 $1.54 2/29/202439,000 shares $70,200.00 -26.7%N/A0.6 $1.80 2/15/202453,200 shares $97,356.00 -11.8%N/A0.8 $1.83 1/31/202460,300 shares $107,334.00 -15.6%N/A0.8 $1.78 1/15/202471,400 shares $123,529.14 +37.3%N/A0.8 $1.73 Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202352,000 shares $93,600.00 -20.4%N/A0.6 $1.80 12/15/202365,300 shares $99,256.00 +147.4%N/A0.7 $1.52 11/30/202326,400 shares $30,360.00 -59.9%N/A0.3 $1.15 11/15/202365,900 shares $82,375.00 +25.8%N/A0.7 $1.25 10/31/202352,400 shares $81,744.00 +5.2%N/A0.6 $1.56 10/15/202349,800 shares $73,704.00 -20.1%N/A0.7 $1.48 9/30/202362,300 shares $85,351.00 +92.3%N/A0.9 $1.37 9/15/202332,400 shares $40,500.00 +18.7%N/A0.6 $1.25 8/31/202327,300 shares $41,496.00 -34.4%N/A0.5 $1.52 8/15/202341,600 shares $50,752.00 +1.2%N/A0.5 $1.22 7/31/202341,100 shares $56,718.00 +18.1%N/A0.3 $1.38 7/15/202334,800 shares $50,112.00 -4.1%N/A0.2 $1.44 6/30/202336,300 shares $49,731.00 -85.1%N/A0.2 $1.37 6/15/2023244,200 shares $402,930.00 +383.6%2.0%1.3 $1.65 5/31/202350,500 shares $106,050.00 +136.0%0.4%0.3 $2.10 5/15/202321,400 shares $49,648.00 -62.6%0.2%0.1 $2.32 4/30/202357,200 shares $120,120.00 +276.3%0.4%0.5 $2.10 4/15/202315,200 shares $37,088.00 -47.0%0.1%0.6 $2.44 3/31/202328,700 shares $67,732.00 +64.9%0.2%1.1 $2.36 3/15/202317,400 shares $34,974.00 +4.2%0.1%0.8 $2.01 2/28/202316,700 shares $39,412.00 -9.2%0.1%1 $2.36 2/15/202318,400 shares $49,864.00 +8.2%0.1%1.2 $2.71 1/31/202317,000 shares $56,440.00 +6.3%0.1%1.1 $3.32 1/15/202316,000 shares $45,561.60 +11.9%0.1%1.1 $2.85 12/30/202214,300 shares $32,604.00 +19.2%0.1%0.7 $2.28 12/15/202212,000 shares $28,972.80 -39.7%0.1%0.6 $2.41 11/30/202219,900 shares $48,556.00 -20.1%0.1%1 $2.44 11/15/202224,900 shares $65,736.00 +69.4%0.2%1.1 $2.64 10/31/202214,700 shares $35,427.00 -2.0%0.1%0.6 $2.41 10/15/202215,000 shares $37,992.00 -29.9%0.1%0.6 $2.53 9/30/202221,400 shares $59,064.00 -4.9%0.2%0.7 $2.76 9/15/202222,500 shares $76,500.00 -17.6%0.2%0.7 $3.40 8/31/202227,300 shares $102,375.00 +31.3%0.2%0.5 $3.75 8/15/202220,800 shares $73,632.00 +181.1%0.2%0.3 $3.54Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. ELDN Short Interest - Frequently Asked Questions What is Eledon Pharmaceuticals' current short interest? Short interest is the volume of Eledon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 106,900 shares of ELDN short. Learn More on Eledon Pharmaceuticals' current short interest. What is a good short interest ratio for Eledon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELDN shares currently have a short interest ratio of 1.0. Learn More on Eledon Pharmaceuticals's short interest ratio. Is Eledon Pharmaceuticals' short interest increasing or decreasing? Eledon Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 106,900 shares, an increase of 193.7% from the previous total of 36,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Eledon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Eledon Pharmaceuticals: Clene Inc. (0.13%), Marker Therapeutics, Inc. (1.68%), Unicycive Therapeutics, Inc. (1.03%), Cara Therapeutics, Inc. (5.56%), NRx Pharmaceuticals, Inc. (6.65%), ProMIS Neurosciences, Inc. (0.17%), Ocuphire Pharma, Inc. (6.33%), BriaCell Therapeutics Corp. (4.83%), Rockwell Medical, Inc. (2.54%), Bolt Biotherapeutics, Inc. (8.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Eledon Pharmaceuticals stock? Short selling ELDN is an investing strategy that aims to generate trading profit from Eledon Pharmaceuticals as its price is falling. ELDN shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eledon Pharmaceuticals? A short squeeze for Eledon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELDN, which in turn drives the price of the stock up even further. How often is Eledon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELDN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Clene Short Interest Data Marker Therapeutics Short Interest Data Unicycive Therapeutics Short Interest Data Cara Therapeutics Short Interest Data NRx Pharmaceuticals Short Interest Data ProMIS Neurosciences Short Interest Data Ocuphire Pharma Short Interest Data BriaCell Therapeutics Short Interest Data Rockwell Medical Short Interest Data Bolt Biotherapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELDN) was last updated on 4/22/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGreat Crypto BullWeiss RatingsExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals